Akums to Acquire Oriflame India's Manufacturing Business for Rs 56 Crore
Akums Drugs and Pharmaceuticals, through its subsidiary Pure and Cure Healthcare Pvt Ltd, will acquire Oriflame India Ltd's manufacturing business for Rs 56 crore. The deal includes two manufacturing facilities in Roorkee and Noida, plus a leased warehouse in Noida. Expected to complete by August 31, 2026, this acquisition marks Akums' entry into colour cosmetics, expanding its capabilities in skincare, wellness, hair care, and cosmetics to serve both Indian and global brands.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 39/100.
Outlets measured: economictimes, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–62/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 23 Jul, 12:47 pm. Other outlets followed.
- 1